000 | 01733 a2200481 4500 | ||
---|---|---|---|
005 | 20250517144706.0 | ||
264 | 0 | _c20180430 | |
008 | 201804s 0 0 eng d | ||
022 | _a1346-8138 | ||
024 | 7 |
_a10.1111/1346-8138.13827 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTaniguchi, Takashi | |
245 | 0 | 0 |
_aCritical contribution of the interleukin-6/signal transducer and activator of transcription 3 axis to vasculopathy associated with systemic sclerosis. _h[electronic resource] |
260 |
_bThe Journal of dermatology _cAug 2017 |
||
300 |
_a967-971 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xpharmacology |
650 | 0 | 4 |
_aCapillaries _xdiagnostic imaging |
650 | 0 | 4 | _aDermoscopy |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNails _xblood supply |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aProto-Oncogene Protein c-fli-1 |
650 | 0 | 4 |
_aReceptors, Interleukin-6 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
650 | 0 | 4 |
_aScleroderma, Systemic _xdrug therapy |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSkin _xdrug effects |
650 | 0 | 4 |
_aVascular Diseases _xdrug therapy |
700 | 1 | _aAsano, Yoshihide | |
700 | 1 | _aFukasawa, Takemichi | |
700 | 1 | _aYoshizaki, Ayumi | |
700 | 1 | _aSato, Shinichi | |
773 | 0 |
_tThe Journal of dermatology _gvol. 44 _gno. 8 _gp. 967-971 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/1346-8138.13827 _zAvailable from publisher's website |
999 |
_c27015281 _d27015281 |